Ann Reg Sci < Ann Rheum Dis < Appl Math Optim

Facettes : Author.f

List of bibliographic references

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]

Ident.	Authors (with country if any)	Title
000069 (2012)	Naomi Schlesinger ; Rieke E. Alten ; Thomas Bardin ; H Ralph Schumacher ; Mark Bloch ; Alberto Gimona ; Gerhard Krammer ; Valda Murphy ; Dominik Richard ; Alexander K. So	Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
000634 (2013)	Monika M. Schoels ; Désirée Van Der Heijde ; Ferdinand C. Breedveld ; Gerd R. Burmester ; Maxime Dougados ; Paul Emery ; Gianfranco Ferraccioli ; Cem Gabay ; Allan Gibofsky ; Juan Jesus Gomez-Reino ; Graeme Jones ; Tore K. Kvien ; Miho M. Murikama ; Norihiro Nishimoto ; Josef S. Smolen	Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
000649 (2013)	N. Schlesinger ; R. Alten ; T. Bardin ; M. Bloch ; A. Shpilsky ; G. Krammer ; T. Kiechle ; A. So	FRI0369 Effect of canakinumab vs triamcinolone acetonide for treatment of gouty arthritis in patients who are unable to use nsaids and colchicine or with severe gouty arthritis
000868 (2009)	B. Combe ; C. Codreanu ; U. Fiocco ; M. Gaubitz ; P P Geusens ; T K Kvien ; K. Pavelka ; P N Sambrook ; J S Smolen ; R. Khandker ; A. Singh ; J. Wajdula ; S. Fatenejad	Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
000918 (2013)	R. Alten ; M. Bloch ; T. Bardin ; A. So ; A. Shpilsky ; J. M. Nebesky ; T. Kiechle ; N. Schlesinger	AB1081 Efficacy and safety of canakinumab vs triamcinolone acetonide in persistent or elderly gouty arthritis patients
000936 (2012)	Y. Shinar ; L. Obici ; I. Aksentijevich ; B. Bennetts ; F. Austrup ; I. Ceccherini ; J M Costa ; A. De Leener ; M. Gattorno ; U. Kania ; I. Kone-Paut ; S. Lezer ; A. Livneh ; I. Moix ; R. Nishikomori ; S. Ozen ; L. Phylactou ; L. Risom ; D. Rowczenio ; T. Sarkisian ; M E Van Gijn ; M. Witsch-Baumgartner ; M. Morris ; H M Hoffman ; I. Touitou	Guidelines for the genetic diagnosis of hereditary recurrent fevers
000B06 (2013)	J-P Pelletier ; C. Cooper ; C. Peterfy ; J-Y Reginster ; M-L Brandi ; O. Bruyère ; R. Chapurlat ; F. Cicuttini ; P G Conaghan ; M. Doherty ; H. Genant ; G. Giacovelli ; M C Hochberg ; D J Hunter ; J A Kanis ; M. Kloppenburg ; J-D Laredo ; T. Mcalindon ; M. Nevitt ; J-P Raynauld ; R. Rizzoli ; C. Zilkens ; F W Roemer ; J. Martel-Pelletier ; A. Guermazi	What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?
000C82 (2005)	F. Tubach ; P. Ravaud ; G. Baron ; B. Falissard ; I. Logeart ; N. Bellamy ; C. Bombardier ; D. Felson ; M. Hochberg ; D. Van Der Heijde ; M. Dougados	Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
000E40 (2013)	C. Roux ; A. Fahrleitner-Pammer ; P. R. Ho ; F. Hawkins ; L. C. Hofbauer ; M. Micaelo ; S. Minisola ; N. Papaioannou ; M. Stone ; J. Wark ; M. C. Zillikens ; I. Ferreira ; S. Siddhanti ; R. B. Wagman ; J. P. Brown	THU0418 Denosumab Versus Risedronate: Efficacy and Safety in Postmenopausal Women Suboptimally Adherent to Alendronate Therapy in a Randomized Open-Label Study
000F55 (2011)	L. Gossec ; J W J. Bijlsma ; C. Bombardier ; H. Canhão ; J. Devlin ; C J Edwards ; V. Hamuryudan ; T K Kvien ; B F Leeb ; E M Martín-Mola ; H. Mielants ; U. Müller-Ladner ; M. Stergaard ; I A Pereira ; C. Ramos-Remus ; J. Zochling ; Maxime Dougados	Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists
001037 (2013)	U. M Ller D Hn ; P. G. Conaghan ; I. Eshed ; A. Boonen ; P. B Yesen ; F. Gandjbakhch ; S. Lillegraven ; P. Bird ; V. Foltz ; C. G. Peterfy ; H. K. Genant ; E. A. Haavardsholm ; F. M. Mcqueen ; M. Stergaard	AB1307 Intra- and interreader reliability of the omeract joint space narrowing score on magnetic resonance imaging and computed tomography in rheumatoid arthritis wrist and metacarpophalangeal joints
001070 (2004)	L B A. Van De Putte ; C. Atkins ; M. Malaise ; J. Sany ; A S Russell ; P L C M. Van Riel ; L. Settas ; J W Bijlsma ; S. Todesco ; M. Dougados ; P. Nash ; P. Emery ; N. Walter ; M. Kaul ; S. Fischkoff ; H. Kupper	Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
001076 (2011)	David T. Felson ; Josef S. Smolen ; George Wells ; Bin Zhang ; Lilian H D. Van Tuyl ; Julia Funovits ; Daniel Aletaha ; Cornelia F. Allaart ; Joan Bathon ; Stefano Bombardieri ; Peter Brooks ; Andrew Brown ; Marco Matucci-Cerinic ; Hyon Choi ; Bernard Combe ; Maarten De Wit ; Maxime Dougados ; Paul Emery ; Daniel Furst ; Juan Gomez-Reino ; Gillian Hawker ; Edward Keystone ; Dinesh Khanna ; John Kirwan ; Tore K. Kvien ; Robert Landewé ; Joachim Listing ; Kaleb Michaud ; Emilio Martin-Mola ; Pamela Montie ; Theodore Pincus ; Pamela Richards ; Jeffrey N. Siegel ; Lee S. Simon ; Tuulikki Sokka ; Vibeke Strand ; Peter Tugwell ; Alan Tyndall ; Desirée Van Der Heijde ; Suzan Verstappen ; Barbara White ; Frederick Wolfe ; Angela Zink ; Maarten Boers	American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
001123 (2006)	B. Combe ; C. Codreanu ; U. Fiocco ; M. Gaubitz ; P P Geusens ; T K Kvien ; K. Pavelka ; P N Sambrook ; J S Smolen ; J. Wajdula ; S. Fatenejad	Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison
001137 (2008)	O. Bruyere ; D. Delferriere ; C. Roux ; J D Wark ; T. Spector ; J-P Devogelaer ; K. Brixen ; S. Adami ; J. Fechtenbaum ; S. Kolta ; J-Y Reginster	Effects of strontium ranelate on spinal osteoarthritis progression
001187 (2013)	M. Boers ; J. R. Kirwan ; G. Wells ; D. Beaton ; L. Gossec ; M.-A. D Gostino ; P. G. Conaghan ; C. O. Bingham ; P. M. Brooks ; R. B. M. Landewé ; L. March ; L. S. Simon ; J. A. Singh ; V. Strand ; P. Tugwell	FRI0521 A framework and process to develop core outcome measurement sets for clinical trials in rheumatology: omeract filter 2.0
001290 (2009)	K. Visser ; W. Katchamart ; E. Loza ; J A Martinez-Lopez ; C. Salliot ; J. Trudeau ; C. Bombardier ; L. Carmona ; D. Van Der Heijde ; J W J. Bijlsma ; D T Boumpas ; H. Canhao ; C J Edwards ; V. Hamuryudan ; T K Kvien ; B F Leeb ; E M Martín-Mola ; H. Mielants ; U. Müller-Ladner ; G. Murphy ; M. Stergaard ; I A Pereira ; C. Ramos-Remus ; G. Valentini ; J. Zochling ; M. Dougados	Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
001330 (2010)	Jérôme Avouac ; Otylia Kowal-Bielecka ; David Pittrow ; Doerte Huscher ; Frank Behrens ; Christopher P. Denton ; Ivan Foeldvari ; Marc Humbert ; Marco Matucci-Cerinic ; Peter Nash ; Christian F. Opitz ; Lewis J. Rubin ; James R. Seibold ; Oliver Distler ; Daniel E. Furst	Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group
001506 (2013)	G. R. Burmester ; A. Rubbert-Roth ; A. Cantagrel ; S. Hall ; P. Leszczynski ; D. Feldman ; M. J. Rangaraj ; G. Roane ; C. Ludivico ; E. Mysler ; L. Rowell ; I. Vranic	SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
001602 (2003)	A. Van Tubergen ; D. Van Der Heijde ; J. Anderson ; R. Landewé ; M. Dougados ; J. Braun ; N. Bellamy ; G. Udrea ; Sj Van Der Linden	Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel
001620 (2006)	T. Pham ; R. Landewé ; S. Van Der Linden ; M. Dougados ; J. Sieper ; J. Braun ; J. Davis ; M. Rudwaleit ; E. Collantes ; R. Burgos-Vargas ; J. Edmonds ; I. Olivieri ; I. Van Der Horst-Bruinsma ; H. Mielants ; M. Stone ; P. Emery ; D. Van Der Heijde	An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Istex/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/ISSN.i -k "Ann Rheum Dis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/ISSN.i  \
                -Sk "Ann Rheum Dis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Istex
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    Ann Rheum Dis
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024